This $1,400,500.00 Project Grant was awarded on August 15, 2023 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Palo Alto Veterans Institute For Research (PAVIR), a nonprofit foundation. The funding will support PAVIR's research efforts over a 3-year period ending on August 14, 2026 to investigate the role of inflammatory astrocyte reactivity in mild traumatic brain injury. PAVIR has extensive experience conducting medical research...
This Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $284,000.00 to the Palo Alto Veterans Institute For Research (PAVIR) to conduct research on novel Fc receptor blockers as potential disease-modifying analgesics. The research will take place from July 1, 2024 to June 30, 2026. PAVIR is a non-profit organization closely affiliated with the VA and Stanford University that has a long history of securing federal grants and...
The U.S. Defense Health Agency awarded a $1,652,030 Project Grant to the Veterans Medical Research Foundation of San Diego to conduct research on the feasibility of combining grape seed extract and milk thistle silymarin extract for lung cancer chemoprevention. This grant is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the public. The...
The U.S. Defense Health Agency awarded a $2,916,605 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the Boston VA Research Institute, Inc. (BVARI) on September 30, 2023. The 4-year award, titled "LONG-TERM PSYCHOLOGICAL AND PHYSICAL HEALTH OUTCOMES FOLLOWING MILITARY DEPLOYMENT: THE VETERANS AFTER-DISCHARGE LONGITUDINAL REGISTRY (PROJECT VALOR)", will fund BVARI's research to investigate risk factors, prevention, and...
This Project Grant award of $260,500.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Palo Alto Veterans Institute for Research (PAVIR) to study the application of electrical current for promoting lymphatic regeneration. The research will be conducted by PAVIR in collaboration with Stanford University as a sub-recipient. The project seeks to experimentally investigate the electrokinetics of collagen matrix materials and...
The Boston VA Research Institute, Inc. was awarded a $293,843 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will support the development of artificial intelligence models to predict pancreatic cancer risk using electronic health records of U.S. veterans from September 2023 through August 2025. As a non-profit research organization partnered with the VA Boston Healthcare System, the Institute conducts biomedical research in...
The Trustees of the University of Pennsylvania will receive $975,000 through a three-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support lung cancer research from July 1, 2023 to June 30, 2026. Through this funding, the University and its Clinical Practices will conduct biomedical research to transform service member healthcare and investigate medical solutions applicable to battlefield medicine....
The federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a $1,126,946 research initiative aimed at cardiovascular risk profiling of deployment-related respiratory diseases. The grant was awarded on November 1, 2024 to the Veterans Bio-Medical Research Institute, Inc., a non-profit research organization located in East Orange, New Jersey. This translational research project investigates innovative...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, is intended to improve the delivery of germline testing for veterans with advanced prostate cancer. The $3,051,639 award, effective September 1, 2025 through August 31, 2029, will support research conducted by the Northern California Institute for Research and Education, Inc. (NCIRE), a non-profit research organization specializing in advanced medical and...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $2,192,538.00 to Vanderbilt University Medical Center to conduct research on "Toxicant-Mediated Pulmonary Hypertension in Southwest Asia Veterans." The award period runs from April 1, 2025 through April 30, 2029. The research aims to investigate the medical issues facing military personnel and veterans, with a focus on transforming...